市場調查報告書
商品編碼
1114169
膝關節植入物市場規模、份額和趨勢分析報告:按程序類型(全膝關節置換、膝關節置換)、按組件類型(固定軸承、移動軸承植入物)、按地區、分部預測,2022-2030Knee Implants Market Size, Share & Trends Analysis Report By Procedure Type (Total Knee Replacement, Revision Knee Replacement), By Component Type (Fixed-Bearing, Mobile-Bearing Implants), By Region, And Segment Forecasts, 2022 - 2030 |
根據 Grandview Research 的一份新報告,到 2030 年,全球膝關節植入物市場預計將達到 174 億美元。
預計 2022 年至 2030 年的複合年增長率為 5.7%。這種增長是由於老年人口的增加和慢性類風濕性關節炎如骨關節炎、類風濕性關節炎和創傷後關節炎的激增。引起關節炎的主要因素包括衰老、身體損傷、遺傳因素、代謝紊亂、感染和免疫系統異常。
預計在預測期內,先進技術和產品的引入將保持行業競爭力和市場增長水平。例如,X3 Advanced Bearing Technology 和 Mako Robotic-Arm Assisted Technology 能夠提供患者特定的 3D 模型來規劃部分膝關節置換術。同樣在 2016 年 3 月,Zimmer Biomet 推出了 Persona 內側全等軸承,旨在最大限度地提高關節穩定性,實現更自然的膝關節運動。
醫療保健領域投資的增加、老年人口的增長以及對微創手術的需求不斷增加是推動關節置換手術採用的主要因素。預計中國和印度等新興經濟體尚未開發的機會將進一步推動市場增長。為對抗 COVID-19,政府主動只允許必要的手術,而大多數膝關節置換術不符合必要手術的定義。而這些限制阻礙了對膝關節植入設備的需求。
例如,NCBI 發表的一項研究發現,2020 年 7 月,關節成形術醫院的每日醫療保險總收入下降了 87%,外科醫生的收入下降了 85%。因此,COVID-19 爆發的早期階段對市場產生了負面影響。由於許多國家禁止醫療產品的進出口,醫療產品的供應鏈也因封鎖而面臨挑戰。新的重大發展,如合作夥伴關係、產品批准、收購和產品發布,預計將在未來幾年對市場產生積極影響。例如,2021 年 11 月,美國 OrthAlign, Inc. 推出了 Lantern,這是一種用於進行全膝關節和部分膝關節置換的手術技術。
全膝關節置換手術將在 2021 年以超過 77.0% 的份額創下最高收入,並有望在預測期內保持其地位
美國和德國等新興國家對該市場做出了巨大貢獻。外科技術的進步和新興經濟體不斷增長的需求預計將成為推動增長的關鍵因素
預計移動軸承植入物細分市場將在預測期內呈現最快的增長。與固定軸承裝置相比,這可歸因於相關優勢,例如磨損更少、性能更長以及可旋轉幾度
預計北美將在 2021 年主導全球市場,並在預測期內保持其主導地位。預計在預測期內,熟練專業人員的可用性以及高昂的程序成本和報銷範圍將推動對膝關節植入物的需求
預計亞太地區將成為預測期內增長最快的地區。印度和中國等新興經濟體蓬勃發展的醫療旅遊業是推動該地區膝關節置換產品需求的關鍵因素。
The global knee implants market size is anticipated to reach USD 17.4 billion by 2030, according to a new report published by Grand View Research, Inc. It is expected t register a CAGR of 5.7% from 2022 to 2030. This growth is attributed to the growing elderly population and the surging prevalence of chronic rheumatic conditions, such as osteoarthritis, rheumatoid arthritis, and post-traumatic arthritis. Primary factors that lead to the occurrence of arthritis are aging, physical injuries, genetic inheritance factors, abnormal metabolism, infections, and immune system abnormalities.
The introduction of advanced technologies and products is anticipated to keep the industry rivalry and market growth at par over the forecast period. For example, X3 Advanced Bearing Technology and Mako Robotic-Arm Assisted Technology have the capabilities of providing a patient-specific 3D model to plan partial knee replacement surgeries. In addition, in March 2016, Zimmer Biomet launched the Persona Medial Congruent Bearing, which is designed to enable more natural motion of the knee by maximizing joint stability.
Increasing investment in the healthcare sector, the growing geriatric population, and the rising demand for minimally invasive surgeries are the major factors driving the adoption of joint replacement procedures. Untapped opportunities in developing economies, such as China and India, are further anticipated to impel market growth. To combat COVID-19, the governments took the initiative of allowing only the necessary surgical procedures and the majority of knee arthroplasty surgery did not meet the definition of essential surgery. Such restrictions then hampered the demand for knee implant devices.
For instance, according to a study published by the NCBI, in July 2020, the total daily Medicare revenue from arthroplasty hospitals decreased by 87% and surgeon revenue by 85%. Thus, the initial phase of the COVID-19 outbreak negatively impacted the market. The medical product supply chain also faced difficulty due to the lockdown, as many countries banned the import and export of medical products. New key developments such as partnerships, product approvals, acquisitions, and product launches are expected to positively impact the market in the coming years. For instance, in November 2021, OrthAlign, Inc., a firm based in the U.S., launched Lantern, which is a surgical technology, used to perform total and partial knee replacements.